Demystifying MasTec: Insights From 8 Analyst Reviews
Portfolio Pulse from Benzinga Insights
MasTec (NYSE:MTZ) has received mixed reviews from 8 analysts in the past three months, with 3 bullish, 3 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for MTZ has been lowered to $75.75 from the previous $106.20, indicating a 28.67% decline. Analysts from Keybanc, Stifel, Goldman Sachs, Barclays, and Citigroup have made various adjustments to their ratings and price targets for MasTec, reflecting changes in market conditions and company performance. MasTec's financial overview shows strong revenue growth but below-average net margin, ROE, and ROA, along with a high debt-to-equity ratio.
January 10, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Analysts have mixed opinions on MasTec, with recent price target adjustments reflecting a more cautious outlook. The average price target has decreased significantly, suggesting potential downside.
The reduction in the average price target by analysts indicates a bearish sentiment, which could lead to a short-term negative impact on MasTec's stock price. The mixed ratings and the significant decline in the average price target may affect investor confidence and could result in downward pressure on the stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100